Bipolar Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Bipolar Disorder Type 1 (BD-1) according to standard psychiatric guidelines (DSM-5)
- People aged between 18 and 70 years old
- People who have been taking lithium as part of their treatment for more than one year
- People whose mood is currently stable — meaning low scores on standard mood assessment scales, no hospital stays, and no changes to their mood-stabilising medication in the past 3 months
- People who are in a general health condition that allows for blood and urine samples to be taken
- People who are enrolled in the French social security system
- People who are able to provide written consent to participate
Who may not be able to join:
- People who have taken melatonin, agomelatine, benzodiazepines, or sleeping tablets in the last 15 days
- People who have taken certain specific medications (ciprofloxacin, dihydralazine, fluvoxamine, or norfloxacin) in the last month, as these can interfere with how the body processes certain substances
- People who currently have a substance use disorder (excluding tobacco)
- People who have chronic kidney disease with significantly reduced kidney function (confirm with trial site)
- People who have experienced jet lag in the last 15 days, or a major life event that may have disrupted their sleep-wake cycle, such as a birth, bereavement, or night shift work
- People who have a diagnosed sleep disorder, such as obstructive sleep apnoea, restless legs syndrome, or narcolepsy
- People who are pregnant or breastfeeding
- People who are under legal guardianship
- People who are unable to understand French or who are unable to read or write
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 01 40 05 42 08
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Ratio between 6-sulfatoxy-melatonin (6-SMT) concentration and creatinin concentration on a 12-hours nocturnal urine collection
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.